calendar

5 catalysts · 5 approval

next 91 dayslessmore

MonWedFri

view

sort

type

therapy area

no tagged catalysts yet

Week of Apr 2, 2018

›Apr 6, 2018approval3049d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS

›Apr 6, 2018approval3049d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS

›Apr 6, 2018approval3049d agoACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

›Apr 6, 2018approval3049d agoACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

›Apr 6, 2018approval3049d agoRUBRACA (RUCAPARIB CAMSYLATE) — FDA approvalrucaparib camsylate

Sponsor: PHARMAAND. Form: TABLET. Route: ORAL

$RDY12.22+0.91%